10 Aug 2023 Biocartis partners with Lilly to explore biomarker testing for NSCLC patients using the Idylla™ Platform Member news
09 Aug 2023 SwiftPharma and ONO Exponential Farming join forces in an exclusive strategic alliance to develop a circular biomanufacturing platform based on plant molecular farming Member news
24 Jul 2023 ‘Human inks’ to 3D printing human tissues: HU3DINKS project brings together expert companies for the development of human tissue-based inks Member news
17 Jul 2023 argenx reports positive topline data from ADHERE study of VYVGART Hytrulo in patients with chronic inflammatory demyelinating polyneuropathy Member news
10 Jul 2023 Sequana Medical announces first patient enrolled in MOJAVE, a US randomized controlled Phase 1/2a study of DSR® 2.0 for treatment of congestive heart failure Member news
20 Jun 2023 argenx initiates second cohort of Phase 2 ARDA study of empasiprubart in multifocal motor neuropathy Member news
16 Jun 2023 Confo Therapeutics enters into research collaboration for GPCR-targeting antibody discovery with AbCellera Member news
05 Jun 2023 ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01 Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
